Evaluation of the effects of vitamin D brain mapping in children with ADHD

Evaluation of the effects of vitamin D supplementation on vitamin status and brain mapping in children with ADHD

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200922048802N1

Enrollment

Registered

2020-11-05

Start date

2020-10-05

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention-deficit hyperactivity disorder. Attention-deficit hyperactivity disorders

Interventions

Intervention 1: The intervention group consumes a 50,000 IU pearl of vitamin D belonging to Zahravi Company every week for 8 weeks. Intervention 2: Control group: They consume one pearl of olive oil e

Eligibility

Sex/Gender

All

Age

7 Years to 13 Years

Inclusion criteria

Inclusion criteria: 7-13 years Resident of Yazd Increase theta wave above 7 hz and decrease beta below 13 hz

Exclusion criteria

Exclusion criteria: IQ less than 80

Design outcomes

Primary

Measure	Time frame
Brain map. Timepoint: Befor and after 8 weeks treatment. Method of measurement: Brain mapping.;Vitamin D. Timepoint: Befor and after 8 weeks treatment. Method of measurement: Using ELISA.	—

Secondary

Measure	Time frame
Weight. Timepoint: Before and after 8 weeks treatment. Method of measurement: Scale.;ADHD symptoms severity. Timepoint: Before and after 8 weeks treatment. Method of measurement: Conners parent rating scale checklist.;C reactive protein. Timepoint: Before and after 8 weeks treatment. Method of measurement: ELISA Kit.;Malondialdehyde. Timepoint: Before and after 8 weeks treatment. Method of measurement: ELISA Kit.;Nitric Oxide. Timepoint: Before and after 8 weeks treatment. Method of measurement: ELISA Kit.	—

Measure

Time frame

Weight. Timepoint: Before and after 8 weeks treatment. Method of measurement: Scale.;ADHD symptoms severity. Timepoint: Before and after 8 weeks treatment. Method of measurement: Conners parent rating scale checklist.;C reactive protein. Timepoint: Before and after 8 weeks treatment. Method of measurement: ELISA Kit.;Malondialdehyde. Timepoint: Before and after 8 weeks treatment. Method of measurement: ELISA Kit.;Nitric Oxide. Timepoint: Before and after 8 weeks treatment. Method of measurement: ELISA Kit.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdieh Hoseinzadeh

Yazd University of Medical Sciences

hoseinzade.mahdie@gmail.com+98 35 3820 1900

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 13, 2026